Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where G. Hurtevent is active.

Publication


Featured researches published by G. Hurtevent.


Modern Pathology | 2011

All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision

Isabelle de Mascarel; Véronique Brouste; Maryam Asad-Syed; G. Hurtevent; Gaëtan MacGrogan

The necessity of excision is debatable when atypia are diagnosed at stereotactic vacuum-assisted breast biopsy (microbiopsy). Among the 287 surgical excisions performed at Institut Bergonié from 1999 to 2009, we selected a case–control study group of 151 excisions; 52 involving all the diagnosed cancers and 99 randomly selected among the 235 excisions without cancer, following atypical microbiopsy (24 flat epithelial atypia; 50 atypical ductal hyperplasia; 14 lobular neoplasia; 63 mixed lesions). Mammographical calcification (type, extension, complete removal) and histological criteria of epithelial atypia (type, number of foci, size/extension), topography and microcalcification extension at microbiopsy were compared according to the presence or absence of cancer at excision. Factors associated with cancer at excision were Breast Imaging Reporting and Data System (BI-RADS5) lesions, large and/or multiple foci of mammographical calcifications, histological type, number, size and extension of atypical foci. Flat epithelial atypia alone was never associated with cancer at excision. BI-RADS5, atypical ductal hyperplasia (alone or predominant) and >3 foci of atypia were identified as independent pejorative factors. There was never any cancer at excision when these pejorative factors were absent (n=31). Presence of one (n=59), two (n=23) or three (n=14) factors was associated with cancer in 24, 15 and 13 cases with an odds ratio=5.8 (95% CI: 3–11.2) for each additional factor. We recommend that mammographical data and histological characteristics be taken into account in the decision-making process after diagnosis of atypia on microbiopsy. With experienced senologists and strict histological criteria, some patients could be spared surgery resulting in significant patient, financial and time advantages.


Diagnostic and interventional imaging | 2012

The inflammatory breast: management, decision-making algorithms, therapeutic principles.

Martine Boisserie-Lacroix; M. Debled; C. Tunon de Lara; G. Hurtevent; M. Asad-Syed; S. Ferron

Inflammatory syndrome is one of the rare emergency breast situations. Its etiology is benign, infectious in most cases. The clinical examination is often self-evident and suggests the diagnosis. But alone it is insufficient, and diagnostic tests are necessary to guide therapy. As essential as it is, mammographys limitations reinforce the benefit of ultrasonography, which in all cases reveals an abscess and has greater sensitivity for detecting a malignant tumor. If the etiology is benign, clinical signs will disappear with medical treatment, with no need for further investigation. While it is legitimate to initiate a trial treatment, it must not delay oncologic management, because of the severity of inflammatory cancer.


34es Journées de la Société Française de Sénologie et de Pathologie Mammaire, 2012"Acquis et limites en Sénologie" [ISBN 978-2-8178-0395-1] | 2013

Modalités de diagnostic du cancer du sein chez la femme âgée : une absence d’acquis, une réflexion nécessaire…

N. Malingret; L.-M. Ecomard; G. MacGrogan; C. Tunon de Lara; M. Asad-Syed; Martine Boisserie-Lacroix; G. Hurtevent; M. Debled

Aucune donnee n’est a notre connaissance disponible concernant les modalites diagnostiques du cancer du sein apres l’age limite du depistage organise, 74 ans en France. Pourtant 20 % des patientes sont agees de 75 ans au moins au diagnostic, une proportion qui va fortement augmenter dans les annees a venir.


CardioVascular and Interventional Radiology | 2015

Single-Centre Experience with Percutaneous Cryoablation of Breast Cancer in 23 Consecutive Non-surgical Patients

Roberto Luigi Cazzato; Christine Tunon de Lara; Xavier Buy; S. Ferron; G. Hurtevent; Marion Fournier; Marc Debled; Jean Palussière


European Journal of Cancer | 2015

Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude

Marc Debled; Gaëtan MacGrogan; C. Breton-Callu; S. Ferron; G. Hurtevent; Marion Fournier; Lionel Bourdarias; Hervé Bonnefoi; Louis Mauriac; Christine Tunon de Lara


Journal de Radiologie Diagnostique et Interventionnelle | 2012

Imagerie des syndromes inflammatoires bénins

S. Ferron; M. Asad-Syed; Martine Boisserie-Lacroix; J. Palussière; G. Hurtevent


Journal de Radiologie Diagnostique et Interventionnelle | 2012

Le sein inflammatoire : conduite à tenir, algorithmes décisionnels, principes thérapeutiques

M. Boisserie-Lacroix; M. Debled; C. Tunon de Lara; G. Hurtevent; M. Asad-Syed; S. Ferron


35es Journées de la Société Française de Sénologie et de Pathologie Mammaire, 2013 "Traitement personnalisé des cancers du sein : impact sur la prise en charge loco-régionale" [ISBN : 978-2-8178-0494-1] | 2013

41. Chirurgie après chimiothérapie néoadjuvante pour un cancer du sein Her2+ localement avancé : envisager systématiquement un traitement conservateur

M. Debled; G. MacGrogan; C. Breton-Callu; S. Ferron; G. Hurtevent; M. Fournier; L. Bourdarias; Hervé Bonnefoi; L. Mauriac; C. Tunon de Lara


Journal De Radiologie | 2012

Le sein inflammatoire: conduite à tenir, algorithmes décisionnels, principes thérapeutiques

Martine Boisserie-Lacroix; M. Debled; C. Tunon De Lara; G. Hurtevent; M. Asad-Syed; S. Ferron


/data/revues/22115684/v93i2/S2211568411000209/ | 2012

Iconography : The inflammatory breast: Management, decision-making algorithms, therapeutic principles

Martine Boisserie-Lacroix; M. Debled; C Tunon de Lara; G. Hurtevent; M. Asad-Syed; S. Ferron

Collaboration


Dive into the G. Hurtevent's collaboration.

Top Co-Authors

Avatar

S. Ferron

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

M. Asad-Syed

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

M. Debled

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Breton-Callu

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

C. Tunon de Lara

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. MacGrogan

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge